Company intelligence / Profile preview

Oasis Biosciences

Vancouver, Washington, United States

Ownership: Private
Employees: ~28
Development stage: Other

Overview

Oasis Diagnostics commercializes proprietary, non-invasive saliva diagnostics and sample collection kits for DNA, RNA, and protein analysis. Their tools are available commercially, supporting research, clinical diagnostics, and point-of-care applications, with a global reach and multiple patented technologies[1][2][3][5].

Therapeutic areas: CardiovascularImmunologyEndocrinologyPulmonologyNeurologyInfectious DiseasesHematologyMen's HealthPsychiatryOncology
Modalities: DeviceSample collectionPoint-of-care diagnosticsMolecular diagnostic technology
Industry: Molecular Diagnostics

Partnerships

ViennaLab Diagnostics (genomic product distribution)Dentulu (teledentistry and salivary testing)Operon S.A. (Spanish partner for genomic tests)

Beyond the preview

Go deeper on Oasis Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oasis Biosciences.

Explore the full profile